The Use of Immunotherapies and Sustained-Release Formulations in the Treatment of Drug Addiction

Will Current Law Support Coercion?

Published in: New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions / Edited by Henrick J. Harwood and Tracy G. Myers (Washington, D.C.: National Academies Press, 2004), Appendix E, p. 173-187

Posted on RAND.org on December 31, 2003

by M. Susan Ridgely, Martin Y. Iguchi, James Chiesa

Read More

Access further information on this document at www.nap.edu

This article was published outside of RAND. The full text of the article can be found at the link above.

While immunotherapies and sustained-release medications are viewed as an attractive solution to society for treatment of drug addiction, past experience suggests that among drug abusing populations some individuals will refuse treatment regimens or participate only sporadically, unless mandated to do so. This appendix addresses the following question: will current law support the coercive use of immunotherapies against drugs of addiction?

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.